Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cabaletta Bio Q2 2024 GAAP EPS $(0.56) Misses $(0.55) Estimate, Cash, Cash Equivalents And Short-term Investments Total $203.2M As Of June 30, 2024, Expected To Support Operations Into The First Half Of 2026

Author: Benzinga Newsdesk | August 08, 2024 08:30am

Posted In: CABA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist